2Seventy Bio Inc reports results for the quarter ended December 31 - Earnings Summary
I'm PortAI, I can summarize articles.
2Seventy Bio IncQ) reported a quarterly adjusted loss of 37 cents per share for the quarter ended December 31, exceeding analyst expectations of a 26-cent loss. Revenue fell 72.6% to $2.93 million, significantly below the expected $12.29 million. The company incurred a total loss of $19.52 million. Despite the disappointing results, shares rose by 68.7% this quarter. Analysts maintain a "hold" rating, with a median 12-month price target of $5.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments